BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance ...

IBEX Limited receives a Strong Buy rating due to profitable growth, selective market choices, and productivity improvements, with a one-year price target of $30.66. The company offers end-to-end ...